Ropharma Bras Cash Flow-to-Debt Ratio
Ropharma Bras cash flow-to-debt ratio. Ropharma Bras (RPH) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2023, meaning its operating cash flow of RON14.80 Million could theoretically repay 0% of its total liabilities (RON289.32 Million) in one year. Check RPH cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Ropharma Bras (2021–2025)
Cash flow-to-debt ratio of Ropharma Bras from 2021 to 2025. Historical debt coverage capacity for Ropharma Bras across 5 annual periods. Check total reinvestment intensity of Ropharma Bras to assess the company's total reinvestment commitment from operating cash flow.
Ropharma Bras Cash Flow-to-Debt Ratio by Year (2021–2025)
Ropharma Bras cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for Ropharma Bras. For the full cash flow conversion analysis, see how efficiently does Ropharma Bras generate cash.
| Year | CF-to-Debt Ratio | Operating CF (RON) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | RON43.16 Million | RON688.42 Million | ▼ -13.9% |
| 2024 | 0.07x | RON40.49 Million | RON555.92 Million | ▲ +30.6% |
| 2023 | 0.06x | RON29.94 Million | RON536.76 Million | ▼ -7.7% |
| 2022 | 0.06x | RON14.65 Million | RON242.40 Million | ▲ +278.9% |
| 2021 | -0.03x | RON-8.64 Million | RON255.62 Million | — |